PharVision Advisers’s Apollo Commercial Real Estate ARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,350
Closed -$216K 132
2025
Q4
$216K Buy
+22,350
New +$224K 0.11% 498
2025
Q3
Sell
-17,519
Closed -$170K 667
2025
Q2
$170K Buy
+17,519
New +$165K 0.24% 220

Other funds holding ARI

PharVision Advisers's ARI Position: Q1 2026 in Review

PharVision Advisers sold out of Apollo Commercial Real Estate (ARI) in Q1 2026, closing a stake of 22,350 shares — an estimated $216K sold.

PharVision Advisers first reported a position in ARI in Q2 2025 and held it in 2 quarters. The position peaked at $216K in Q4 2025. 271 funds tracked by Wall St. Rank hold ARI as of Q1 2026.

  • PharVision Advisers reported no remaining Apollo Commercial Real Estate position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 22,350 Apollo Commercial Real Estate shares in Q1 2026, an estimated $216K.
  • PharVision Advisers first reported a position in Apollo Commercial Real Estate in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's Apollo Commercial Real Estate position peaked at $216K in Q4 2025.
  • 271 funds tracked by Wall St. Rank held Apollo Commercial Real Estate as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.